ATOS logo

ATOS
Atossa Therapeutics Inc

64,114
Mkt Cap
$111.51M
Volume
533,652.00
52W High
$1.66
52W Low
$0.5526
PE Ratio
-3.84
ATOS Fundamentals
Price
$0.8633
Prev Close
$0.8896
Open
$0.90
50D MA
$0.8915
Beta
1.22
Avg. Volume
1.35M
EPS (Annual)
-$0.2026
P/B
1.93
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
New Strong Sell Stocks for Oct. 22
ATOS, BLIN and CLTP have been added to the Zacks Rank #5 (Strong Sell) List on Oct. 22, 2025.
Zacks·13d ago
News Placeholder
More News
News Placeholder
Atossa Therapeutics Highlights Progress in RECAST DCIS Platform Trial at Early Detection Research Conference; Laura Esserman, MD, MBA, to Discuss Active-Surveillance Strategy and Novel Endocrine Agents
Atossa Therapeutics Highlights Progress in RECAST DCIS Platform Trial at Early Detection Research Conference; Laura Esserman, MD, MBA, to Discuss Active-Surveillance Strategy and Novel Endocrine...
PR Newswire·14d ago
News Placeholder
Atossa Therapeutics to Present at the Maxim Growth Summit 2025
Atossa Therapeutics to Present at the Maxim Growth Summit 2025 Atossa Therapeutics to Present at the Maxim Growth Summit 2025 PR Newswire SEATTLE, Oct. 15, 2025 Invites New Investors to Learn More...
PR Newswire·20d ago
News Placeholder
Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness
Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to...
PR Newswire·21d ago
News Placeholder
New Strong Sell Stocks for Oct. 14th
AR, BTCS and ATOS have been added to the Zacks Rank #5 (Strong Sell) List on October 14, 2025.
Zacks·21d ago
News Placeholder
Atossa Advances Global Patent Strategy for Z-Endoxifen with New Protection in Israel and Ongoing Renewals
Atossa Advances Global Patent Strategy for Z-Endoxifen with New Protection in Israel and Ongoing Renewals Atossa Advances Global Patent Strategy for Z-Endoxifen with New Protection in Israel and...
PR Newswire·22d ago
News Placeholder
Atos shares climb 4% after reporting stronger half-year liquidity position
investing.com·4mo ago
News Placeholder
BofA assesses the impact of foreign tax in budget bill on European software names
Investing.com - European software companies stand to be hit by a section of a massive Republican budget bill which would tax foreign investors in the United States.
investing.com·5mo ago
News Placeholder
Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year?
Zacks·6mo ago
News Placeholder
Atos to launch reverse stock split on March 25 to stabilize shares
investing.com·8mo ago

Latest ATOS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.